108 related articles for article (PubMed ID: 2310207)
1. Elevated plasma histamine levels in systemic sclerosis (scleroderma).
Falanga V; Soter NA; Altman RD; Kerdel FA
Arch Dermatol; 1990 Mar; 126(3):336-8. PubMed ID: 2310207
[TBL] [Abstract][Full Text] [Related]
2. Augmented interleukin-6 secretion in collagen-stimulated peripheral blood mononuclear cells from patients with systemic sclerosis.
Gurram M; Pahwa S; Frieri M
Ann Allergy; 1994 Dec; 73(6):493-6. PubMed ID: 7998663
[TBL] [Abstract][Full Text] [Related]
3. Aberrant serum hyaluronan and hyaluronidase levels in scleroderma.
Neudecker BA; Stern R; Connolly MK
Br J Dermatol; 2004 Mar; 150(3):469-76. PubMed ID: 15030329
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of soluble CD31 in patients with systemic sclerosis (SSc): association with limited cutaneous SSc.
Sato S; Komura K; Hasegawa M; Fujimoto M; Takehara K
J Rheumatol; 2001 Nov; 28(11):2460-5. PubMed ID: 11708419
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of tissue inhibitor of metalloproteinases 2 in systemic sclerosis: a preliminary study.
Dziankowska-Bartkowiak B; Waszczykowska E; Łuczyńska M; Zalewska A; Sysa-Jedrzejowska A
Med Sci Monit; 2002 Feb; 8(2):CR108-12. PubMed ID: 11859283
[TBL] [Abstract][Full Text] [Related]
6. Animal model of sclerotic skin. II. Bleomycin induced scleroderma in genetically mast cell deficient WBB6F1-W/W(V) mice.
Yamamoto T; Takahashi Y; Takagawa S; Katayama I; Nishioka K
J Rheumatol; 1999 Dec; 26(12):2628-34. PubMed ID: 10606374
[TBL] [Abstract][Full Text] [Related]
7. Serum aminoterminal propeptide of type III procollagen in progressive systemic sclerosis and localized scleroderma.
Zachariae H; Halkier-Sørensen L; Heickendorff L
Acta Derm Venereol; 1989; 69(1):66-70. PubMed ID: 2563612
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors.
Kawaguchi Y; Takagi K; Hara M; Fukasawa C; Sugiura T; Nishimagi E; Harigai M; Kamatani N
Arthritis Rheum; 2004 Jan; 50(1):216-26. PubMed ID: 14730619
[TBL] [Abstract][Full Text] [Related]
9. Pseudoscleroderma associated with cancer.
Kikuchi K; Hoashi T; Yazawa N; Tamaki K
Clin Exp Dermatol; 2006 May; 31(3):381-3. PubMed ID: 16681582
[TBL] [Abstract][Full Text] [Related]
10. Elevated serum BAFF levels in patients with systemic sclerosis: enhanced BAFF signaling in systemic sclerosis B lymphocytes.
Matsushita T; Hasegawa M; Yanaba K; Kodera M; Takehara K; Sato S
Arthritis Rheum; 2006 Jan; 54(1):192-201. PubMed ID: 16385515
[TBL] [Abstract][Full Text] [Related]
11. Elevated matrix metalloproteinase-9 in patients with systemic sclerosis.
Kim WU; Min SY; Cho ML; Hong KH; Shin YJ; Park SH; Cho CS
Arthritis Res Ther; 2005; 7(1):R71-9. PubMed ID: 15642145
[TBL] [Abstract][Full Text] [Related]
12. Systemic sclerosis sine scleroderma: demographic, clinical, and serologic features and survival in forty-eight patients.
Poormoghim H; Lucas M; Fertig N; Medsger TA
Arthritis Rheum; 2000 Feb; 43(2):444-51. PubMed ID: 10693887
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of skin sclerosis by 15deoxy delta12,14-prostaglandin J2 and retrovirally transfected prostaglandin D synthase in a mouse model of bleomycin-induced scleroderma.
Kohno S; Endo H; Hashimoto A; Hayashi I; Murakami Y; Kitasato H; Kojima F; Kawai S; Kondo H
Biomed Pharmacother; 2006 Jan; 60(1):18-25. PubMed ID: 16337105
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of surfactant protein D as a serum marker for evaluating pulmonary fibrosis in patients with systemic sclerosis.
Asano Y; Ihn H; Yamane K; Yazawa N; Kubo M; Fujimoto M; Tamaki K
Arthritis Rheum; 2001 Jun; 44(6):1363-9. PubMed ID: 11407696
[TBL] [Abstract][Full Text] [Related]
15. [Systemic sclerosis--clinical course and treatment possibilities].
Szymańska E; Maj M; Rudnicka L
Przegl Lek; 2005; 62(12):1538-41. PubMed ID: 16786791
[TBL] [Abstract][Full Text] [Related]
16. Increased serum interleukin 23 in patients with systemic sclerosis.
Komura K; Fujimoto M; Hasegawa M; Ogawa F; Hara T; Muroi E; Takehara K; Sato S
J Rheumatol; 2008 Jan; 35(1):120-5. PubMed ID: 18085738
[TBL] [Abstract][Full Text] [Related]
17. Tumor-associated antigens in systemic sclerosis and systemic lupus erythematosus: associations with organ manifestations, immunolaboratory markers and disease activity indices.
Szekanecz E; Szucs G; Szekanecz Z; Tarr T; Antal-Szalmás P; Szamosi S; Szántó J; Kiss E
J Autoimmun; 2008 Dec; 31(4):372-6. PubMed ID: 18926664
[TBL] [Abstract][Full Text] [Related]
18. [Systemic sclerosis].
Gustafsson R
Nord Med; 1994; 109(8-9):236-7. PubMed ID: 7937033
[TBL] [Abstract][Full Text] [Related]
19. Localized scleroderma and systemic sclerosis: is there a connection?
Gupta RA; Fiorentino D
Best Pract Res Clin Rheumatol; 2007 Dec; 21(6):1025-36. PubMed ID: 18068859
[TBL] [Abstract][Full Text] [Related]
20. Nursing problems of patients with systemic sclerosis.
Sierakowska M; Sierakowski S; Lewko J; Jankowiak B; Kowalczuk K; Krajewska-Kułak E
Adv Med Sci; 2007; 52 Suppl 1():147-52. PubMed ID: 18232102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
